Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 22% ± 6% |
Insufficient scRNA-seq data for expression of ATG4A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 827.80 | 1445 / 1445 | 100% | 15.30 | 183 / 183 |
kidney | 100% | 944.01 | 89 / 89 | 100% | 18.55 | 901 / 901 |
liver | 100% | 950.25 | 226 / 226 | 100% | 16.83 | 406 / 406 |
lung | 100% | 1196.99 | 578 / 578 | 100% | 19.46 | 1155 / 1155 |
pancreas | 100% | 1073.03 | 328 / 328 | 100% | 16.47 | 178 / 178 |
stomach | 100% | 1016.85 | 359 / 359 | 100% | 15.22 | 286 / 286 |
thymus | 100% | 1106.44 | 653 / 653 | 100% | 22.55 | 605 / 605 |
uterus | 100% | 637.91 | 170 / 170 | 100% | 19.34 | 459 / 459 |
breast | 100% | 799.46 | 459 / 459 | 100% | 21.40 | 1117 / 1118 |
prostate | 100% | 731.10 | 245 / 245 | 100% | 19.40 | 501 / 502 |
bladder | 100% | 742.29 | 21 / 21 | 100% | 16.00 | 502 / 504 |
brain | 99% | 510.38 | 2625 / 2642 | 100% | 12.76 | 705 / 705 |
intestine | 100% | 871.02 | 966 / 966 | 99% | 14.97 | 523 / 527 |
adrenal gland | 100% | 1026.15 | 258 / 258 | 99% | 24.75 | 228 / 230 |
skin | 100% | 637.33 | 1807 / 1809 | 98% | 13.90 | 463 / 472 |
ovary | 100% | 431.32 | 180 / 180 | 98% | 9.39 | 421 / 430 |
adipose | 100% | 842.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.51 | 29 / 29 |
muscle | 100% | 1352.21 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 963.71 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.85 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.10 | 1 / 1 |
blood vessel | 100% | 724.49 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 939.40 | 859 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 564.46 | 893 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 73% | 5.11 | 58 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000423 | Biological process | mitophagy |
GO_0006914 | Biological process | autophagy |
GO_0015031 | Biological process | protein transport |
GO_0016485 | Biological process | protein processing |
GO_0034727 | Biological process | piecemeal microautophagy of the nucleus |
GO_0006629 | Biological process | lipid metabolic process |
GO_0006508 | Biological process | proteolysis |
GO_0006501 | Biological process | C-terminal protein lipidation |
GO_0035973 | Biological process | aggrephagy |
GO_0051697 | Biological process | protein delipidation |
GO_0000045 | Biological process | autophagosome assembly |
GO_0005737 | Cellular component | cytoplasm |
GO_0019786 | Molecular function | protein-phosphatidylethanolamide deconjugating activity |
GO_0008234 | Molecular function | cysteine-type peptidase activity |
GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ATG4A |
Protein name | Cysteine protease ATG4A (EC 3.4.22.-) (AUT-like 2 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 2) (Autophagin-2) (Autophagy-related protein 4 homolog A) (HsAPG4A) (hAPG4A) Cysteine protease (EC 3.4.22.-) Autophagy related 4A cysteine peptidase |
Synonyms | hCG_21686 APG4A AUTL2 |
Description | FUNCTION: Cysteine protease that plays a key role in autophagy by mediating both proteolytic activation and delipidation of ATG8 family proteins . The protease activity is required for proteolytic activation of ATG8 family proteins: cleaves the C-terminal amino acid of ATG8 proteins to reveal a C-terminal glycine . Exposure of the glycine at the C-terminus is essential for ATG8 proteins conjugation to phosphatidylethanolamine (PE) and insertion to membranes, which is necessary for autophagy . Preferred substrate is GABARAPL2 followed by MAP1LC3A and GABARAP . Protease activity is also required to counteract formation of high-molecular weight conjugates of ATG8 proteins (ATG8ylation): acts as a deubiquitinating-like enzyme that removes ATG8 conjugated to other proteins, such as ATG3 . In addition to the protease activity, also mediates delipidation of ATG8 family proteins . Catalyzes delipidation of PE-conjugated forms of ATG8 proteins during macroautophagy . Compared to ATG4B, the major protein for proteolytic activation of ATG8 proteins, shows weaker ability to cleave the C-terminal amino acid of ATG8 proteins, while it displays stronger delipidation activity . Involved in phagophore growth during mitophagy independently of its protease activity and of ATG8 proteins: acts by regulating ATG9A trafficking to mitochondria and promoting phagophore-endoplasmic reticulum contacts during the lipid transfer phase of mitophagy . . FUNCTION: Cysteine protease that plays a key role in autophagy by mediating both proteolytic activation and delipidation of ATG8 family proteins. . FUNCTION: Cysteine protease that plays a key role in autophagy by mediating both proteolytic activation and delipidation of ATG8 family proteins. . FUNCTION: Cysteine protease that plays a key role in autophagy by mediating both proteolytic activation and delipidation of ATG8 family proteins. . |
Accessions | F8W7J2 ENST00000394892.2 ENST00000372246.7 ENST00000345734.7 [Q8WYN0-2] ENST00000457035.5 ENST00000343524.9 A0A0A0MT61 G5E979 H7BYM2 ENST00000372232.8 [Q8WYN0-1] Q8WYN0 |